Dimension Therapeutics Inc logo

DMTX - Dimension Therapeutics Inc News Story

$5.95 0.0  0.0%

Last Trade - 06/11/17

Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £11.9m
Position in Universe th / 6715

BRIEF-Ultragenyx Pharmaceutical comments on Dimension Therapeutics' announcement

Mon 2nd October, 2017 2:25pm
Oct 2 (Reuters) - Ultragenyx Pharmaceutical:  
    * Ultragenyx Pharmaceutical comments on dimension 
therapeutics' announcement that co's offer is a "superior 
proposal" in its merger agreement with regenxbio 
    * Ultragenyx Pharmaceutical says is "pleased" that dimension 
board determined that all-cash offer to buy dimension for $6.00 
per share is a superior proposal 
Source text for Eikon:  ID:nGNXOEQCJa  
Further company coverage:  DMTX.O  
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.